Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retlirafusp Alfa + Apatinib + Chemotherapy in Second-Line Pancreatic Cancer
NCT07773363Phase 2Not yet recruiting
- Sponsor
- Tangdu Hospital
- Start
- Aug 2026
- Primary completion
- Dec 2027
01
Overview
A Phase 2 trial of retlirafusp alfa in pancreatic cancer (PC), sponsored by Tangdu Hospital. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
retlirafusp alfa
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07773363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07773363.